- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Drug Pipelines
- March 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Clinical Trials
- February 2024
- 180 Pages
Global
From €2900EUR$3,000USD£2,493GBP
- Drug Pipelines
- February 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Report
- January 2024
- 169 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Report
- August 2023
- 295 Pages
Global
From €9184EUR$9,500USD£7,894GBP
- Report
- May 2023
- 450 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- October 2023
- 181 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 181 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- June 2023
- 112 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 145 Pages
Global
From €3045EUR$3,150USD£2,617GBP
- Report
- January 2024
- 243 Pages
Global
€4829EUR$4,995USD£4,150GBP
- Report
- December 2023
- 306 Pages
Global
€4829EUR$4,995USD£4,150GBP
- Report
- July 2023
- 218 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- July 2023
- 200 Pages
Global
From €4350EUR$4,500USD£3,739GBP
- Report
- October 2023
- 85 Pages
United States
From €4592EUR$4,750USD£3,947GBP
- Report
- October 2021
- 433 Pages
Global
From €2250EUR$2,493USD£2,002GBP
- Report
- May 2022
- 196 Pages
Global
From €5075EUR$5,250USD£4,362GBP
Interleukins are a group of cytokines, or proteins, that are involved in the regulation of the immune system. They are produced by a variety of cells, including T cells, B cells, and macrophages, and are involved in a wide range of biological processes, including inflammation, cell growth, and differentiation. Genomics has enabled researchers to better understand the role of interleukins in the immune system, and to develop new therapies for a variety of diseases.
In recent years, the interleukin market has grown significantly, with a number of companies developing new therapies and diagnostic tests. Companies such as AbbVie, Amgen, and Novartis are developing new interleukin-based therapies for a variety of diseases, while companies such as Genentech and Merck are developing diagnostic tests to detect interleukin levels in patients. Additionally, a number of biotechnology companies are developing new interleukin-based therapies for a variety of diseases. Show Less Read more